HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain disease.

Abstract
Congenital muscular dystrophies due to defects in genes encoding proteins involved in α-dystroglycan (α-DG) glycosylation are a heterogeneous group of muscle disorders variably associated with central nervous system and eye abnormalities. One of the more severe is muscle-eye-brain disease (MEB). Mutations in genes coding for proven or putative glycosyltransferases (POMT1, POMT2, POMGnT1, fukutin, FKRP, and LARGE), the DPM3 gene encoding a DOL-P-Man synthase subunit, and the DAG1 gene encoding α-dystroglycan, have been associated with altered α-DG glycosylation. We report new POMGnT1 mutations and evaluate protein expression in 3 patients and 2 foetuses with variably severe MEB features. We identify two new point mutations (c.643C>T, c.1863delC), one new intragenic rearrangement (deletion of exons 2-8), and a new intron retention (between exons 21 and 22) resulting from a known point mutation c.1895+1G>T. Our study provides further evidence that rearrangements of the POMGnT1 gene are relatively common. Importantly, if heterozygous, they can be missed on standard genomic DNA sequencing. POMGNT1 protein analysis in 3 patients showed that the severity of the phenotype does not correlate with protein expression. Cerebral MRI is important for identifying MEB and α-dystroglycanopathy phenotypes in children and foetuses, and hence for directing the genetic analysis.
AuthorsS Saredi, A Ardissone, A Ruggieri, E Mottarelli, L Farina, R Rinaldi, E Silvestri, C Gandioli, S D'Arrigo, F Salerno, L Morandi, P Grammatico, C Pantaleoni, I Moroni, M Mora
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 318 Issue 1-2 Pg. 45-50 (Jul 15 2012) ISSN: 1878-5883 [Electronic] Netherlands
PMID22554691 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • N-Acetylglucosaminyltransferases
  • protein O-mannose beta-1,2-N-acetylglucosaminyltransferase
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Fatal Outcome
  • Female
  • Fetal Diseases (diagnosis, enzymology, genetics)
  • Gene Rearrangement (genetics)
  • Genetic Predisposition to Disease (genetics)
  • Humans
  • Male
  • N-Acetylglucosaminyltransferases (genetics, metabolism)
  • Phenotype
  • Point Mutation (genetics)
  • Pregnancy
  • Severity of Illness Index
  • Walker-Warburg Syndrome (diagnosis, enzymology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: